Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey
Lung · 2024
DOI: 10.1007/s00408-024-00714-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung, 2024. Verfasst von Danica Brister und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University Medical Centre, 3U9, 1280 Main St. West, Hamilton, ON, L8S 4L8, Canada. Hauptthemen laut MEDLINE: Cough, Quality of Life, Cost of Illness. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Merck Canada.
Abstract (Originalsprache)
INTRODUCTION: Chronic cough (persisting for ≥ 8 weeks) is a common disorder that includes refractory chronic cough (RCC; cough that persists despite treatment of underlying disease) and unexplained chronic cough (UCC; cough with no identifiable cause). We evaluated self-reported health-related quality of life (HR-QoL) and work/activity impairment associated with RCC/UCC in Canada. METHODS: Our exploratory study included Canadians in the Leger Opinion Panel with RCC or UCC. Key entry criteria were ≥ 18 years of age, cough for ≥ 8 weeks, not currently smoking/quit ≥ 1 year ago, no serious respiratory disease or lung cancer, and not taking angiotensin-converting enzyme inhibitors. Respondents completed a 30-min online survey with general and cough-specific HR-QoL questionnaires, including the EuroQol (EQ) visual analogue scale (VAS), EQ-5-dimension 5-level (EQ-5D-5L), cough severity VAS, Leicester Cough Questionnaire (LCQ), and Work Productivity and Activity Impairment-Specific Health Problem (WPAI-SPH). RESULTS: Of 49,076 individuals who completed the chronic cough screening questionnaire (July 30-September 1, 2021), 1,620 (3.3%) met entry criteria for RCC/UCC and 1,046 (2.1%) completed the survey. The mean age of respondents was 45 years and 61% were female. Respondents reported impairments in global HR-QoL (EQ-VAS 73.8, 61% with anxiety/depression on the EQ-5D-5L) and cough-specific HR-QoL (mean cough severity VAS score 29.7, LCQ index 15.2). Work and non-work activities were reduced by 34% and 30%, respectively, on the WPAI-SPH. CONCLUSION: RCC/UCC is prevalent in Canada and associated with impaired HR-QoL, particularly in mental health domains. Additional support and management options may be required to fully address this burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, McMaster University Medical Centre, 3U9, 1280 Main St. West, Hamilton, ON, L8S 4L8, Canada.
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, ON, Canada.
- Merck Canada Inc., Kirkland, QC, Canada.
- Medical Department, MSD, Madrid, Spain.
- Department of Medicine, McMaster University Medical Centre, 3U9, 1280 Main St. West, Hamilton, ON, L8S 4L8, Canada. satiai@mcmaster.ca.
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, ON, Canada. satiai@mcmaster.ca.
Förderung
- Merck Canada
Zitieren
APA
Brister, D., Khan, S., Abraham, T., Laventure, S., Sahakian, S., Juliá, B., & Satia, I. (2024). Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey. Lung. https://doi.org/10.1007/s00408-024-00714-1
Vancouver
Brister D, Khan S, Abraham T, Laventure S, Sahakian S, Juliá B, et al. Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey. Lung. 2024. doi:10.1007/s00408-024-00714-1
BibTeX
@article{Brister2024,
author = {Brister, Danica and Khan, Sana and Abraham, Ted and Laventure, Samuel and Sahakian, Sevag and Juliá, Berta and Satia, Imran},
title = {Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey},
journal = {Lung},
year = {2024},
doi = {10.1007/s00408-024-00714-1}
}
EUVIMED